HepaTx announces the issuance of US patent entitled “Methods and Composition for Producing Hepatocyte-Like Cells”

PALO ALTO, Calif., May 9, 2022 /PRNewswire/ -- The US Patent Office (USPTO) has granted HepaTx patent number 11291691 covering the company's technology to manufacture hepatocyte-like cells to treat liver disease. The patent titled "Methods and Composition for Producing Hepatocyte-Like...

Click to view original post